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Incremental prognostic value of multi-slice computed
tomography coronary angiography over coronary artery calcium
scoring in patients with suspected coronary artery disease
Abstract
Aims The purpose of this study was to assess the relationship between calcium scoring (CS) and
multi-slice computed tomography coronary angiography (MSCTA) and to determine if MSCTA has an
incremental prognostic value to CS. Methods and results In 432 patients (59% male, age 58 +/- 11
years) referred for cardiac evaluation owing to suspected coronary artery disease (CAD), CS and
64-slice MSCTA were performed. The following events were combined in a composite endpoint:
all-cause mortality, non-fatal infarction, and unstable angina requiring revascularization. CS was 0 in
147 (34%) patients, CS 1-99 was present in 122 (28%), CS 100-399 in 75 (17%), CS 400-999 in 56
(13%), and CS >/= 1000 in 32 (7%). MSCTA was normal in 133 (31%) patients, MSCTA 30-50%
stenosis was observed in 190 (44%), and MSCTA >/=50% stenosis in 109 (25%). During follow-up
[median 670 days (25th-75th percentile: 418-895)], an event occurred in 21 patients (4.9%). After
multivariate correction for CS, MSCTA >/= 50% stenosis, the number of diseased segments, obstructive
segments, and non-calcified plaques were independent predictors with an incremental prognostic value
to CS. Conclusion MSCTA provides additional information to CS regarding stenosis severity and plaque
composition. This additional information was shown to translate into incremental prognostic value over
CS.
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Abstract 
 
Aims: The purpose of this study was to assess the relationship between calcium scoring 
(CS) and multi-slice computed tomography coronary angiography (MSCTA) and to 
determine if MSCTA has an incremental prognostic value to CS. 
Methods and Results: In 432 patients (59% male, age 58±11 years) referred for cardiac 
evaluation due to suspected coronary artery disease (CAD), CS and 64-slice MSCTA 
were performed. The following events were combined in a composite endpoint: all cause 
mortality, non-fatal infarction, and unstable angina requiring revascularization. CS was 0 
in 147 (34%) patients, CS 1-99 was present in 122 (28%), CS 100-399 in 75 (17%), CS 
400-999 in 56 (13%), and CS≥1000 in 32 (7%). MSCTA was normal in 133 (31%) 
patients, MSCTA 30-50% stenosis was observed in 190 (44%), and MSCTA ≥50% 
stenosis in 109 (25%). During follow-up (median 670 days (25-75
th
 percentile:418-895), 
an event occurred in 21 patients (4.9%) patients. After multivariate correction for CS, 
MSCTA≥50% stenosis, the number of diseased segments, obstructive segments, and non-
calcified plaques were independent predictors with an incremental prognostic value to 
CS.  
Conclusion: MSCTA provides additional information to CS regarding stenosis severity 
and plaque composition. This additional information was shown to translate into 
incremental prognostic value over CS.  
 
Keywords: imaging, atherosclerosis, and prognosis. 
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Introduction 
Non-invasive imaging plays an important role in the diagnosis and prognosis of coronary 
artery disease (CAD). The development of non-invasive anatomic imaging techniques 
such as coronary calcium scoring (CS) and multi-slice computed tomography coronary 
angiography (MSCTA) have resulted in substantially increased interest in non-invasive 
imaging of atherosclerosis. 
Extensive data are available supporting the value of CS in risk stratification and 
patients with increased CS are generally considered to have a higher likelihood of future 
cardiac events. The majority of data however have been obtained in asymptomatic 
patients at low to intermediate risk although the technique may also be useful in 
symptomatic patients.(1-4) 
 Direct non-invasive detection of luminal narrowing has become possible with the 
introduction of MSCTA. Preliminary studies addressing the prognostic value of MSCTA 
have demonstrated a low risk for events in case of a normal MSCTA study compared to a 
higher risk in the presence of significant CAD on MSCTA.(5-8) Importantly, MSCTA is 
not restricted to luminography and the technique allows simultaneous visualization of the 
vessel wall. As a result, also non-stenotic lesions can be identified and even some 
information on plaque composition can be derived.(9) This may be an important feature 
of the technique as several plaque characteristics observed on MSCTA have been linked 
to acute coronary syndromes in retrospective studies.(10, 11) Nevertheless, only limited 
prospective data are currently available supporting this notion. 
Accordingly, both CS and MSCTA may be useful for risk stratification in patients 
with suspected CAD, it is unclear however if the information regarding stenosis severity 
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and plaque composition on MSCTA may provide additional prognostic information to 
CS. To answer this clinical question amongst others we have started a prospective 
registry that addresses the prognostic value of MSCTA in relation to baseline 
characteristics as well as other imaging techniques.(12) The purpose of the present study 
was to assess the relationship between observations on CS and MSCTA and to determine 
whether the information regarding stenosis severity and plaque composition on MSCTA 
translates into incremental prognostic value over CS alone.
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Methods 
Patient selection 
The study population consisted of patients with suspected coronary artery disease (CAD) 
who were clinically referred for further cardiac assessment because of chest pain, a 
positive exercise ECG test, or a high risk profile for cardiovascular disease as part of an 
ongoing study protocol addressing the prognostic value of MSCTA in relation to other 
imaging techniques. From this prospective registry, results addressing the incremental 
prognostic value of MSCTA over myocardial perfusion imaging have been recently 
published.(12) Patients were enrolled at the University Hospital in Zurich, Switzerland, 
and at the Leiden University Medical Center, The Netherlands. The included patients 
prospectively underwent a CS scan followed by MSCTA. Exclusion criteria were: cardiac 
arrhythmias, renal insufficiency (defined as a glomerular filtration rate <30 ml/min), 
known hypersensitivity to iodine contrast media, and pregnancy. In addition, patients 
with an uninterpretable MSCTA examination were excluded. The pre-test likelihood of 
CAD was determined using the Diamond and Forrester method, with a risk threshold of 
<13.4% for low risk, >87.2% for high risk, and between 13.4 and 87.2% for intermediate 
risk, as previously described.(13) The study was approved by the local ethics committee 
in both participating centers.  
 
 
CS and MSCTA protocol 
Patients were scanned using a 64-slice CT scanner (Aquillion64, Toshiba Medical 
Systems, Tokyo, Japan; or General Electrics LightSpeed VCT, Milwaukee, WI, US). 
Before CS and MSCTA examinations, the patient’s heart rate and blood pressure were 
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monitored. In the absence of contraindications, patients with a heart rate exceeding the 
threshold of 65 beats per minute were administered beta-blocking medication (50-100 mg 
metoprolol, oral or 5-10 mg metoprolol, intravenous). Before the helical scan, a non-
enhanced low dose ECG-gated scan was performed to measure CS. The CS scan was 
prospectively triggered at 70% or 75% of the R-R interval and performed using the 
following scan parameters: 4x3.0 mm or 2.5 mm; gantry rotation time, 350-500 
milliseconds; tube voltage, 120 kV; and tube current, 200-250 mA. 
The CS scan was used to determine the start and end positions of the MSCTA 
examination. The helical scan was performed using a collimation of 64 x 0.5 mm or 
64x0.625 mm. All scan parameters have been previously published.(14, 15) 
Datasets were reconstructed from the retrospectively gated raw data. Images were 
reconstructed with an effective slice thickness of 0.3 or 0.5. Coronary arteries were 
evaluated using the reconstruction dataset with the least motion artifacts, typically an 
end-diastolic phase.  
The effective dose of the CS and MSCTA scans was estimated from the product 
of the dose-length product and an organ weighing factor [k=0.014 mSv x (mGy x cm)
-1
] 
for the chest as the investigated anatomical region.(16)
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Data Analysis 
Post-processing of the CS and MSCTA examinations was performed on dedicated 
workstations (Vitrea2, Vital Images, USA and Advantage, GE healthcare, USA). The CS 
was calculated using the Agatston method.(17) MSCTA angiograms were examined 
using the axial slices, curved multiplanar reconstructions (MPR), and maximum intensity 
projections (MIP). Coronary anatomy was assessed in a standardized manner by dividing 
the coronary artery tree into 17 segments according to the modified American Heart 
Association classification. First segments were classified based on the maximum luminal 
diameter stenosis. Normal MSCTA was defined as completely normal anatomy or 
minimal wall irregularities <30%, non-significant CAD was defined as the presence of 
luminal narrowing with a maximal luminal diameter stenosis <50%, and significant CAD 
was defined as the presence of an atherosclerotic lesion exceeding the threshold of 50% 
maximal luminal diameter stenosis. After assessment of stenosis severity, plaque 
composition was determined in all diseased segments (non-significant or significant CAD 
on MSCTA). Plaque composition was graded as non-calcified plaque (plaques having 
lower density compared with the contrast-enhanced lumen), calcified plaque (plaques 
with high density), and mixed plaque (containing elements of both non-calcified and 
calcified plaque). 
 
Follow-up 
Patient follow-up data were gathered using clinical visits or standardized telephone 
interviews. A composite endpoint was construed using the following events: all cause 
mortality, non-fatal myocardial infarction, and unstable angina requiring 
revascularization. Non-fatal infarction was defined based on criteria of typical chest pain, 
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elevated cardiac enzyme levels, and typical changes on the ECG. Unstable angina was 
defined according to the European Society of Cardiology guidelines as acute chest pain 
with or without the presence of ECG abnormalities, and negative cardiac enzyme 
levels.(18) Patients with stable complaints undergoing an early elective revascularization 
within 60 days after imaging with CS and MSCTA were excluded from the survival 
analysis. 
 
Statistical analysis 
Continuous variables were expressed as mean and standard deviation, and categorical 
baseline data were expressed in numbers and percentages. Cox regression analysis was 
used to determine the prognostic value of CS, and MSCTA variables. First univariate 
analysis of baseline CS and MSCTA variables was performed using the composite 
endpoint of all cause mortality, non-fatal infarction, and unstable angina requiring 
revascularization. For each variable a hazard ratio with a 95%-confidence interval (95%-
CI) was calculated. The predictive value of CS was assessed using binary cutoff values 
(CS >0, CS ≥100, CS ≥ 400, and CS ≥ 1000). For the survival analysis of MSCTA, 
plaque burden (number of (non) significantly diseased segments) and plaque composition 
(number of segments with non-calcified, mixed or calcified plaque) were analyzed as 
continuous variables. Finally, multivariate models were created to assess the independent 
predictive value of MSCTA corrected for CS and baseline clinical variables. The 
incremental value of MSCTA over CS and baseline clinical variables was assessed by 
calculating the global chi-square. 
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Statistical analyses were performed using SPSS software (version 12.0, SPSS Inc, 
Chicago, IL, USA). A p-value <0.05 was considered statistically significant.
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Results 
The current study population, derived from our prospective registry,(12) consisted of 533 
patients presenting with suspected CAD at the University Hospital Zurich (n=270) and at 
the Leiden University Medical Center (n=263). The demographics in the two populations 
were similar. In 24 (4.5%) of these patients the MSCTA examination was uninterpretable 
due to the presence of motion artifacts, increased noise due to a high body mass index, 
and breathing. In addition, 35 patients (6.9%) were lost to follow-up, and an early 
revascularization occurred in 42 (8.3%) patients. After exclusion of these patients, a total 
of 432 remained for further analysis. The baseline characteristics of the patient 
population are presented in Table 1. In summary, the average age of the study cohort was 
58±11 years and 58% of patients were men. A low or intermediate pre-test likelihood was 
observed in respectively 24% and 65% of patients. A high pre-test likelihood was 
observed in 11%. 
 
CS and MSCTA results 
The average CS of the cohort was 290±730. Calcium was absent in 117 (34%) patients, a 
CS of 1-99 was observed in 122 (28%), a CS between 100 and 399 in 75 (17%), a CS 
between 400 and 999 in 56 (13%), and a CS ≥ 1000 was present in 32 (7%) patients. 
MSCTA was normal in 133 (31%) patients, and atherosclerosis (non-significant or 
significant CAD) was present in the remaining 299 (69%) patients. Within the patients 
with atherosclerosis, non-significant CAD was observed in 190 (44%), and significant 
CAD was present in 109 (25%) patients. For the GE scanner the estimated average 
radiation dose for the MSCTA protocol was 18.3±5.9 mSv, and the average radiation 
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dose for the CS protocol was 1.2±0.6 mSv. For the Toshiba scanner the estimated 
average radiation dose for the coronary angiography protocol was 17.6±5.6 mSv and the 
estimated radiation dose for the CS protocol was 1.5±0.7 mSv. 
 
Relationship between CS and stenosis severity and plaque composition assessed on 
MSCTA 
 
Stenosis severity. Figure 1 illustrates the MSCTA findings in patients with increasing CS 
values. In patients without any coronary calcium, MSCTA was normal in 80%. Non-
calcified plaque was observed in the remaining 20% of patients (7% of the total study 
population). Importantly, significant CAD was observed in 4% of patients with a CS of 0. 
An example of a patient with a CS of 0 and a large non-calcified plaque on MSCTA, 
confirmed on conventional coronary angiography is shown in Figure 2. In patients with 
coronary calcifications non-significant and significant lesions were present in all but a 
few patients. However the relationship between CS and significant CAD on MSCTA was 
less evident. Particularly in patients with an intermediate CS between 100 and 1000, 
significant CAD was observed in approximately 50% of patients. In patients with a high 
CS ≥ 1000, non-significant CAD was observed in 30% of patients. 
 
Plaque composition. MSCTA enables assessment of plaque composition in addition to 
stenosis severity. Figure 3 shows the distribution of segments with non-calcified plaque, 
mixed plaque and calcified plaque in each CS category as a percentage of the total 
diseased segments. In patients with CS of 0 all 76 diseased segments showed non-
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calcified plaque. With increasing CS categories the percentage of segments with calcified 
plaque contributing to the total of diseased segments increased. MSCTA was however 
able to identify a large proportion of diseased segments with elements of non-calcified 
plaque (either mixed plaque or non-calcified plaque) in each category.  
 
Follow-up results 
A median follow-up time of 670 days (25-75
th
 percentile: 418-895) was obtained, during 
which the composite endpoint occurred in 21 patients (4.9%). All cause death was 
reported in 6 patients (1.4%), whereas non-fatal myocardial infarction occurred in 8 
patients (1.8%) and 7 patients (1.6%) were revascularized due to unstable angina 
pectoris. 
 
Survival analysis 
Univariate analysis of CS and MSCTA categories is shown in Table 2. Within the CS 
cutoff categories CS ≥ 100, CS ≥ 400 and CS ≥ 1000 were significant predictors of 
events. The highest hazard ratio was observed when using a cutoff of 1000. On MSCTA 
several variables reached statistical significance. The presence of any stenosis (non-
significant (30-50% stenosis) or significant (≥50% stenosis) as well as the presence of 
significant CAD (≥50% stenosis) both were strong significant predictors. When regarding 
plaque burden, both the number of diseased segments as well as the number of segments 
with significant CAD were significant univariate predictors. When regarding plaque 
composition, the number of segments with non-calcified plaque and the number segments 
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with mixed plaque were also significant predictors of events. The number of segments 
with calcified plaque was not a significant predictor of events. 
 
Event rates 
The annualized event rate in patients without any coronary calcium was 1.1%. 
Increasingly higher CS was associated with increasingly higher annualized event rates, 
the annualized event rate was 1.4% in patients with a CS 1-99, 3.7% in patients with a CS 
100-399, and 4.8% in patients with a CS 400-999. The highest annualized event rate of 
8.5% was observed in patients with a CS ≥ 1000. 
When regarding MSCTA, an event rate of 0.8% was observed in patients with a 
normal MSCTA (completely normal or minor wall irregularities); while in patients with 
atherosclerosis (non-significant and/or significant CAD) the annualized event rate was 
3.5%. In patients with non-significant CAD the annualized event rate was 2.1%, versus 
5.9% in patients with significant CAD.  
 
Independent and incremental prognostic value of MSCTA over CS 
To determine the independent prognostic value of MSCTA, multivariate models were 
created including all MSCTA variables corrected for age, gender and CS ≥ 1000. Table 3 
shows that the presence of significant CAD, the number of diseased segments, 
obstructive segments, segments with non-calcified plaque, and the number of segments 
with mixed plaque remained independent predictors. Furthermore plaque burden and 
plaque composition provided incremental prognostic value over clinical variables and 
MSCTA as shown in Figures 4 and 5. These results suggest that MSCTA may provide 
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additional prognostic information. In particular, the number of segments with significant 
CAD and and the number of segments with non-calcified plaque provided significant 
incremental prognostic value over CS. The number of mixed plaques provided borderline 
significant (p=0.058) incremental prognostic value to CS.  
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Discussion 
The main finding of the current study was that MSCTA may provide additional anatomic 
information regarding stenosis severity and plaque composition compared to CS. 
Furthermore this information offers important prognostic information which is 
incremental to CS for risk stratification. 
 
CS and MSCTA for atherosclerosis detection 
In asymptomatic patients, CS may be useful to identify the presence of atherosclerosis 
and thus identify patients that may be at higher risk than recognized based on traditional 
risk assessment.(19) Vice versa, absence of calcium on the other hand in general implies 
a low likelihood of events.(20) However in a small proportion of patients with a negative 
CS, non-calcified plaque has been observed.(21, 22) Indeed, in certain subpopulations, 
such as those at higher risk or in symptomatic patients the prevalence of non-calcified 
plaque may be higher.(23-25) Akram et al. specifically studied the relationship between 
symptomatic status and the prevalence of non-significant and significant CAD in patients 
with a CS of 0 and observed 22% non-significant and significant CAD and 8% significant 
CAD in symptomatic patients.(23) In the current study non-significant or significant 
CAD was identified on MSCTA in 20% of patients with a CS of 0, whereas significant 
CAD was observed in 4%. Accordingly, particularly in symptomatic populations a small 
proportion of patients with atherosclerosis may not be recognized by CS.  
Considering patients with evidence of coronary calcifications, a positive 
association has been observed between CS and the presence of significant CAD on 
MSCTA and conventional coronary angiography.(26, 27) Indeed in the current study the 
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prevalence of significant CAD paralleled increasing CS categories. Nevertheless, in a 
substantial proportion of patients with extensive calcifications, significant CAD was 
absent on MSCT, indicating somewhat lower specificity of CS to diagnose significant 
CAD in line with previous investigations.(28, 29) Since particularly in symptomatic 
patients identification of significant CAD is of importance for guiding clinical 
management (including decisions for potential revascularization), MSCTA may provide 
incremental diagnostic information to CS in this regard. 
  
Prognostic value of CS and MSCTA 
A considerable amount of evidence regarding risk stratification is available with CS in 
asymptomatic patients.(19, 20, 30-33) Although less frequently studied, also in 
symptomatic patients CS has been shown to provide important prognostic information (1-
4) In the study by Detrano et al. a 6 times higher event rate was observed in patients with 
a CS above the median compared to those with a CS below the median.(1) 
The prognostic value of MSCTA has been studied less extensively.(5-8) In the 
largest study thus far by Min et al, a cohort of 1,127 patients undergoing 16-slice MSCT 
was evaluated.(6) The prognostic value of the Duke Prognostic Coronary Artery Disease 
Index was assessed and event rates for all cause mortality ranging between 0.3% for none 
or mild atherosclerosis (stenosis <50%) to 15% for mild to moderate left main disease 
were observed in a period of 2 years. Similar findings were reported in smaller studies by 
Gilard et al and Pundziute et al.(5, 7) Furthermore, recently published results from our 
current prospective registry have demonstrated an incremental prognostic value of 
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MSCTA over myocardial perfusion imaging using single photon emission computed 
tomography.(12)  
To our knowledge the current study is the first study assessing the incremental 
prognostic value of both stenosis severity and plaque composition on MSCTA over CS. 
In a previous study however, the incremental value of plaque burden, derived by non-
invasive coronary angiography with electron beam computed tomography, over CS was 
assessed by Ostrom and colleagues.(34) The authors showed that plaque burden, defined 
as the number of non-significantly or significantly diseased vessels, had independent and 
incremental value in predicting all-cause mortality independent of age, gender, 
conventional risk factors, and CS. Similar findings were recently reported by Rubinshtein 
et al.(8) Accordingly, in combination with our own observations, it appears that non-
invasive measures of the extent and severity of stenosis provide incremental prognostic 
information over CS. 
Importantly, assessment of plaque composition may further enhance risk 
stratification. However, only limited prospective data are available addressing the 
potential relationship between plaque composition on MSCTA and outcome. When 
exploring plaque composition in the current study, the number of segments with non-
calcified plaque as well as the number of segments with mixed plaque was shown to be 
independently associated with increased risk for events. Interestingly, no such relation 
was observed for the number of segments with calcified plaque. An explanation may be 
that CS is more accurate at quantifying calcium burden. Furthermore when regarding 
only the number of calcified plaques on MSCT the calcium in mixed plaques is 
disregarded. Secondly, another explanation may be that non-calcified plaque is more 
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important from a prognostic standpoint. Currently two previous studies have addressed 
the prognostic value of plaque composition assessed by MSCTA.(7, 12) Pundziute et al 
observed that the number of mixed plaques was a significant predictor when corrected for 
baseline clinical variables.(7) In addition, we recently showed that plaque composition on 
MSCTA provides incremental prognostic value over myocardial perfusion imaging.(12)  
 
Limitations 
Even though the diagnostic accuracy of MSCTA is high, uninterpretable images are still 
encountered in a small percentage of patients due to motion because of high or irregular 
heart rates or breathing during the examination. It is however anticipated that the number 
of uninterpretable studies will continue to decrease with newer generation scanners. 
Another potential limitation of MSCTA is the use of iodinated contrast media. As a result 
MSCTA is contraindicated in patients with renal insufficiency or known hypersensitivity 
to iodine contrast media. Currently 64-slice MSCTA is still associated with a 
significantly higher radiation exposure than CS, although the radiation dose of MSCTA 
will decrease with the use of dedicated dose reduction techniques that have recently 
become available.(35-38)  
 
Conclusion 
Non-invasive anatomic imaging using CS and MSCTA is useful for the detection of 
atherosclerosis; MSCTA however provides additional information to CS regarding 
stenosis severity and plaque composition. This additional information was shown to 
translate into incremental value for risk stratification. 
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Legends 
 
Figure 1 The relationship between increasingly higher CS categories and the prevalence 
of normal coronary anatomy (completely normal or minor wall irregularities), non-
significant CAD (MSCTA < 50% stenosis) and significant CAD (MSCTA ≥ 50% 
stenosis) on MSCTA. 
Abbreviation: CAD: coronary artery disease; CS: calcium score; MSCTA: multi-slice 
computed tomography. 
 
Figure 2 Case example of a 54-year old male patient presenting with atypical complaints. 
On CS no coronary calcifications were observed. However a large significant non-
calcified plaque was detected in the left anterior descending artery on MSCTA (Panels A-
C), which was confirmed on conventional coronary angiography (Panel D). 
Abbreviation: CS: calcium score; MSCTA: multi-slice computed tomography. 
 
Figure 3 The distribution of segments with non-calcified plaque, mixed plaque and 
calcified plaque as a percentage of the total diseased segments on MSCTA per CS 
category. In patients with a CS 0, all 76 diseased segments showed non-calcified plaque. 
With increasing CS categories the percentage of diseased segments with calcified plaque 
increased. Nevertheless, non-calcified plaque and mixed plaque were still observed in a 
large proportion of diseased segments in each CS category. 
Abbreviation: CS: calcium score; MSCTA: multi-slice computed tomography coronary 
angiography. 
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Figure 4 Bar graphs illustrating the incremental prognostic value (depicted by chi-square 
value on the y-axis) of significant CAD (≥50% stenosis) on MSCTA and plaque burden 
(defined as the number of diseased or segments with significant CAD on MSCTA) over 
age, gender and CS. CS has a significant incremental prognostic value over age and 
gender (#). A further incremental prognostic value over age, gender and CS was observed 
with the addition of MSCTA (*). 
Abbreviations: CS: calcium score; MSCTA: multi-slice computed tomography. 
 
Figure 5 Bar graphs illustrating the incremental prognostic value (depicted by chi-square 
value on the y-axis) of MSCTA plaque composition variables over age, gender and CS. 
CS has a significant incremental prognostic value over age and gender (#). A further 
incremental prognostic value over age, gender and CS was observed with the addition of 
MSCTA (*). 
Abbreviations: CS: calcium score; MSCTA: multi-slice computed tomography. 
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Tables 
 
Abbreviations: BMI: body mass index; CAD: coronary artery disease. 
Table 1. Patient characteristics  
 Total 
 
n = 432 
Gender (male)  59% 
Age (yrs) 58±11 
Risk Factors  
  Diabetes 121 (28%) 
  Hypertension 244 (57%) 
  Hypercholesterolemia 170 (39%) 
  Family history CAD 157 (36%) 
  Current Smoking 119 (28%) 
  Obesity (BMI ≥ 30) 92 (21%) 
Pre-test likelihood of CAD  
  Low 102 (24%) 
  Intermediate 281 (65%) 
  High 49 (11%) 
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Abbreviations: CAD: coronary artery disease; CS: calcium score; MSCTA: multi-slice 
computed tomography coronary angiography. 
# : number of 
 
Table 2. Univariate CS and MSCTA predictors of coronary events 
 HR (95%-CI) p-value 
CS   
  Calcium score (per unit increase in CS score) 1.00 (1.00-1.01) 0.019 
  Any calcium 3.2 (0.9-10.9) 0.062 
  Calcium score ≥100 3.9 (1.5-10.2) 0.005 
  Calcium score ≥400 3.5 (1.5-8.3) 0.004 
  Calcium score ≥1000 4.1 (1.5-11.3) 0.006 
MSCTA   
  Atherosclerosis 4.3 (1.0-18.6) 0.048 
  Significant CAD 3.9 (1.7-9.3) 0.002 
  # of Diseased segments 1.2 (1.08-1.3) <0.001 
  # Segments with significant CAD 1.4 (1.2-1.6) <0.001 
  # Segments with non-calcified plaque 1.2 (1.07-1.4 ) 0.003 
  # Segments with mixed plaque 1.3 (1.07-1.5) 0.005 
  # Segments with calcified plaque 1.09 (0.9-1.3) 0.254 
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Abbreviations: CAD: coronary artery disease. 
# : number of 
 
Table 3. Multivariate models for the prediction of coronary events  
  
HR (95%-CI) p-value 
Model 1* Atherosclerosis 4.5 (0.9-21.3) 0.056 
 Calcium score ≥1000 4.0 (1.3-12.4) 0.016 
Model 2* Significant CAD 3.6 (1.4-9.4) 0.009 
 Calcium score ≥1000 2.9 (0.9-9.3) 0.064 
Model 3* # Diseased segments 1.2 (1.1-1.3) 0.006 
 Calcium score ≥1000 2.0 (0.6-6.9) 0.268 
Model 4* # Segments with significant CAD 1.3 (1.1-1.5) 0.003 
 Calcium score ≥1000 2.6 (0.7-9.3) 0.148 
Model 5* # Segments with non-calcified plaque 1.3 (1.1-1.4) 0.001 
 Calcium score ≥1000 5.8 (1.9-18.2) 0.003 
Model 6* # Segments with mixed plaque 1.2 (1.0-1.4) 0.039 
 Calcium score ≥1000 3.6 (1.1-11.6) 0.029 
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Abstract 
 
Aims: The purpose of this study was to assess the relationship between calcium scoring 
(CS) and multi-slice computed tomography coronary angiography (MSCTA) and to 
determine if MSCTA has an incremental prognostic value to CS. 
Methods and Results: In 432 patients (59% male, age 58±11 years) referred for cardiac 
evaluation due to suspected coronary artery disease (CAD), CS and 64-slice MSCTA 
were performed. The following events were combined in a composite endpoint: all cause 
mortality, non-fatal infarction, and unstable angina requiring revascularization. CS was 0 
in 147 (34%) patients, CS 1-99 was present in 122 (28%), CS 100-399 in 75 (17%), CS 
400-999 in 56 (13%), and CS≥1000 in 32 (7%). MSCTA was normal in 133 (31%) 
patients, MSCTA 30-50% stenosis was observed in 190 (44%), and MSCTA ≥50% 
stenosis in 109 (25%). During follow-up (median 670 days (25-75
th
 percentile:418-895), 
an event occurred in 21 patients (4.9%) patients. After multivariate correction for CS, 
MSCTA≥50% stenosis, the number of diseased segments, obstructive segments, and non-
calcified plaques were independent predictors with an incremental prognostic value to 
CS.  
Conclusion: MSCTA provides additional information to CS regarding stenosis severity 
and plaque composition. This additional information was shown to translate into 
incremental prognostic value over CS.  
 
Keywords: imaging, atherosclerosis, and prognosis. 
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